Evidence map›Paper›PMID 28463648›Full record

Observational studyAmerican journal of respiratory and critical care medicine2017

A Functional Toll-Interacting Protein Variant Is Associated with Bacillus Calmette-Guérin-Specific Immune Responses and Tuberculosis.

Javeed A Shah, Munyaradzi Musvosvi, Muki Shey, David J Horne, Richard D Wells, Glenna J Peterson, Jeffery S Cox, Michelle Daya, Eileen G Hoal, Lin Lin and 5 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in American journal of respiratory and critical care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. DiminishedOpen forum infectious diseases · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. TOLLIP Optimizes Dendritic Cell Maturation to Lipopolysaccharide andJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  15. Article
  16. Article
  17. Toll-Interacting Protein in Pulmonary Diseases. Abiding by the Goldilocks Principle.American journal of respiratory cell and molecular biology · 2021
    Review
  18. Article
  19. Genetics and evolution of tuberculosis pathogenesis: New perspectives and approaches.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Javeed A Shah1 University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0002-2997-7988
Munyaradzi Musvosvi3 South African Tuberculosis Vaccine Initiative and.
Muki Shey3 South African Tuberculosis Vaccine Initiative and.
David J Horne1 University of Washington School of Medicine, Seattle, Washington.
Richard D Wells1 University of Washington School of Medicine, Seattle, Washington.
Glenna J Peterson1 University of Washington School of Medicine, Seattle, Washington.
Jeffery S Cox5 University of California Berkeley, Berkeley, California.
Michelle Daya6 Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Eileen G Hoal6 Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa.
Lin Lin7 Department of Statistics, Pennsylvania State University, University Park, Pennsylvania; and.
Raphael Gottardo8 Fred Hutchinson Cancer Research Center, Seattle, Washington.
Willem A Hanekom3 South African Tuberculosis Vaccine Initiative and.
Thomas J Scriba3 South African Tuberculosis Vaccine Initiative and.
Mark Hatherill3 South African Tuberculosis Vaccine Initiative and.
Thomas R Hawn1 University of Washington School of Medicine, Seattle, Washington.
University of Washington · USUniversity of Cape Town · ZAStellenbosch University · ZAFred Hutch Cancer Center · USPennsylvania State University · USTuBerculosis Vaccine Initiative · NLUniversity of California, Berkeley · US

Funding

The role of Listeria cyclic-di-AMP during infection and immunityP01AI063302 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI PORTNOY, DANIEL A · 2004 to 2025
$45.5M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Innate Immunogenetics & Human InfectionsK24AI089794 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2010 to 2014
$746k
TOLLIP and Tuberculosis ImmunopathogenesisK08AI102971 · NIAID · UNIVERSITY OF WASHINGTON · PI SHAH, JAVEED ALI · 2013 to 2016
$708k
NIAID NIH HHS K08 AI102971NIAID NIH HHS K24 AI089794NIAID NIH HHS L30 AI091018NIAID NIH HHS N01 AI070022NIAID NIH HHS P01 AI063302NIAID NIH HHS T32 AI007044
6 · The paper itself

Abstract

rationaleThe molecular mechanisms that regulate tuberculosis susceptibility and bacillus Calmette-Guérin (BCG)-induced immunity are mostly unknown. However, induction of the adaptive immune response is a critical step in host control of Mycobacterium tuberculosis. Toll-interacting protein (TOLLIP) is a ubiquitin-binding protein that regulates innate immune responses, including Toll-like receptor signaling, which initiate adaptive immunity. TOLLIP variation is associated with susceptibility to tuberculosis, but the mechanism by which it regulates tuberculosis immunity is poorly understood.

objectivesTo identify functional TOLLIP variants and evaluate the role of TOLLIP variation on innate and adaptive immune responses to mycobacteria and susceptibility to tuberculosis.

methodsWe used human cellular immunology approaches to characterize the role of a functional TOLLIP variant on monocyte mRNA expression and M. tuberculosis-induced monocyte immune functions. We also examined the association of TOLLIP variation with BCG-induced T-cell responses and susceptibility to latent tuberculosis infection. MEASUREMENTS AND MAIN

resultsWe identified a functional TOLLIP promoter region single-nucleotide polymorphism, rs5743854, which was associated with decreased TOLLIP mRNA expression in infant monocytes. After M. tuberculosis infection, TOLLIP-deficient monocytes demonstrated increased IL-6, increased nitrite, and decreased bacterial replication. The TOLLIP-deficiency G/G genotype was associated with decreased BCG-specific IL-2

conclusionsTOLLIP deficiency is associated with decreased BCG-specific T-cell responses and increased susceptibility to tuberculosis. We hypothesize that the heightened antibacterial monocyte responses after vaccination of TOLLIP-deficient infants are responsible for decreased BCG-specific T-cell responses. Activating TOLLIP may provide a novel adjuvant strategy for BCG vaccination.

Indexed as

HumansImmunity, InnateIntracellular Signaling Peptides and ProteinsMycobacterium bovisPolymorphism, Single NucleotideProspective StudiesTuberculosisIntracellular Signaling Peptides and ProteinsTOLLIP protein, humanadaptive immunitybacillus Calmette-GuéringeneticsToll-interacting proteintuberculosis

Identifiers

PMID28463648
PMCPMC5564674
OpenAlexW2611032097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.